Trial Profile
Multicentre randomised trial of chlorambucil versus chlorambucil plus rituximab versus rituximab alone in extranodal marginal zone bcell lymphoma of mucosa associated lymphoid tissue (malt lymphoma)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Oct 2023
Price :
$35
*
At a glance
- Drugs Chlorambucil (Primary) ; Rituximab (Primary)
- Indications Marginal zone B-cell lymphoma
- Focus Therapeutic Use
- 06 Oct 2023 Results (n=401) assessing Early Complete Response as Validated Surrogate Marker in Extranodal Marginal Zone Lymphoma Systemic Therapy published in the Blood
- 18 Jul 2017 Results of a MALT lymphoma prognostic index generated using data from 401 patients enrolled in this trial, published in the Blood.
- 29 Mar 2017 Results published in the Journal of Clinical Oncology